• Bifendate Suppresses Autophagy and Lipid Accumulation Mechan

  2026-05-20

  Yuan et al. (2022) elucidate how bifendate (DDB) impairs multiple stages of autophagy, notably inhibiting autophagosome-lysosome fusion and lysosomal acidification, thereby reducing oleic acid-induced intracellular lipid droplet buildup. These findings clarify a mechanistic link between bifendate's autophagy modulation and hepatic lipid metabolism, offering new angles for metabolic liver disease research.

• Gepotidacin: Mechanistic Insights & Assay Impact in Antibact

  2026-05-19

  Discover the molecular mechanism of Gepotidacin (GSK2140944) and its transformative role in antibacterial research. This article provides an in-depth analysis of practical assay design, integrating advanced scientific insight and comparative context beyond prior reviews.

• QPRT-P2Y11 Axis Drives Breast Cancer Invasion via MLC Phosph

  2026-05-19

  Liu et al. (2021) elucidate a mechanistic link between upregulated QPRT expression and enhanced invasiveness of breast cancer cells, implicating myosin light chain (MLC) phosphorylation via purinergic P2Y11 receptor signaling. Pharmacological inhibition of P2Y11 reverses this invasive phenotype, providing new insight into cancer cell migration and potential research avenues for metastasis intervention.

• Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro Pro

  2026-05-18

  This study identifies Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) using high-throughput enzymatic screening of ~6,000 compounds. The findings clarify Merbromin's mechanism of inhibition and provide a structural basis for developing future antiviral agents.

• 25-Hydroxycholesterol, AMPK, and Macrophage Immunometabolism

  2026-05-18

  Xiao et al. (2024) reveal how tumor-associated macrophages use 25-hydroxycholesterol (25HC) to activate lysosomal AMPK signaling, driving an immunosuppressive phenotype via STAT6 and metabolic reprogramming. These insights highlight CH25H as a modifiable immunometabolic checkpoint with implications for improving tumor immunotherapy outcomes.

• HyperTrap Heparin HP Column: High-Resolution Protein Purific

  2026-05-17

  The HyperTrap Heparin HP Column leverages HyperChrom Heparin HP Agarose for precise, high-yield isolation of critical biomolecules—including coagulation factors and growth factors. Its unique combination of fine particle size and chemical robustness sets a new standard for workflow reliability and scalability in affinity chromatography applications.

• Sulfamonomethoxine in Veterinary and Aquatic Systems: Mechan

  2026-05-16

  Explore Sulfamonomethoxine’s scientific foundation as a broad-spectrum veterinary antibiotic, its precise action on folate biosynthesis, and evidence-based protocols for environmental and aquatic safety. This article provides actionable insights for researchers and stewards seeking unique, data-driven guidance.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-05-15

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction and analysis, especially in workflows where EDTA would interfere with downstream assays. This product should be used for applications requiring preservation of native protein states, but is not suitable where EDTA-based inhibition is necessary or where DMSO sensitivity is a concern.

• Caffeine’s Translational Power: Mechanisms, Models, and Stra

  2026-05-15

  This thought-leadership article explores the mechanistic underpinnings and translational applications of caffeine (1,3,7-trimethylpurine-2,6-dione) in cancer, metabolic, and cardiovascular research. By blending experimental evidence, protocol essentials, and strategic perspective, it positions caffeine as a pivotal tool in next-generation translational workflows, while benchmarking emerging paradigms such as ALDH2 activator development.

• PPAR-α–Mediated TF Expression Drives Tumor Progression in pL

  2026-05-14

  A recent multiomic study reveals that linoleic acid promotes tumor progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC) by upregulating tissue factor (TF) expression through activation of PPAR-α. These findings connect lipid metabolism with tumor microenvironment modulation and highlight TF as a potential therapeutic target.

• Adenosine Triphosphate (ATP): Precision Control in Mitochond

  2026-05-14

  Explore the pivotal role of Adenosine Triphosphate (ATP) in precision mitochondrial metabolism research. This article reveals advanced insights into ATP’s regulatory mechanisms, grounded in the latest molecular findings and optimized for assay reliability.

• Z-WEHD-FMK: Precision Caspase Inhibition in Inflammation Res

  2026-05-13

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) delivers irreversible, highly selective inhibition of inflammatory caspases, enabling advanced study of pyroptosis and Golgi fragmentation. This article details applied workflows, troubleshooting strategies, and new insights from recent research, helping researchers unlock the full potential of this APExBIO reagent.

• Polymyxin B Sulfate: Applied Protocols for Gram-Negative Inf

  2026-05-13

  Polymyxin B (sulfate) offers robust bactericidal activity for multidrug-resistant Gram-negative infection models and advanced immune modulation assays. This guide details optimized workflows, troubleshooting strategies, and real-world protocol parameters, bridging recent resistance dynamics research with actionable laboratory applications.

• MLN8237 (Alisertib): Applied Workflows in Cancer Biology Res

  2026-05-12

  MLN8237 (Alisertib) from APExBIO empowers researchers to dissect Aurora A kinase’s role in oncogenesis with high selectivity and reproducible performance. This guide details optimized workflows, data-driven protocol parameters, and troubleshooting insights—extending recent mechanistic findings into actionable cancer biology applications.

• Belinostat (PXD101): Precision Epigenetic Modulation in Canc

  2026-05-12

  Explore how Belinostat (PXD101) enables precision epigenetic cancer research through rigorous HDAC inhibition, with a unique focus on advanced assay interpretation and translational relevance. Discover how new in vitro methodologies reshape drug evaluation for bladder and prostate cancer.

15962 records 1/1065 page Next 12345 下5页 Last page